A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment
The studies of breast cancer heavily rely on the availability of experimental animal models. An ideal model of breast cancer is not only required to mimic the whole processes of tumor progress and metastasis, but also required to provide a normal human mammary microenvironment for the breast cancer cells to proliferate and metastasize. Numerous mouse models have been introduced in the literature but failed to achieve the two requirements simultaneously. In this study, we developed a novel human breast tissue-derived orthotopic and metastatic (BOM) mouse model of breast cancer, in which the normal human breast tissues were implanted subcutaneously to create a normal human mammary microenvironment, after which the human breast cancer cells were inoculated into the implants. The BOM model not only mimicked the whole processes of tumor progress and metastasis, but also allowed the orthotopic human breast cancer cells to proliferate in the normal human mammary microenvironment, and finally metastasize preferentially to the distant human tissues. Consequently, the BOM model contributed to the orthotopic tumor formation of 100% (11/11) and the metastatic tumor formation of 72.7% (8/11).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:120 |
|---|---|
| Enthalten in: |
Breast cancer research and treatment - 120(2010), 2 vom: 21. Apr., Seite 337-44 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Jue [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
147336-22-9 |
|---|
| Anmerkungen: |
Date Completed 16.06.2010 Date Revised 16.03.2010 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10549-009-0391-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM187681139 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM187681139 | ||
| 003 | DE-627 | ||
| 005 | 20231223180521.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10549-009-0391-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0626.xml |
| 035 | |a (DE-627)NLM187681139 | ||
| 035 | |a (NLM)19350386 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Jue |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.06.2010 | ||
| 500 | |a Date Revised 16.03.2010 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The studies of breast cancer heavily rely on the availability of experimental animal models. An ideal model of breast cancer is not only required to mimic the whole processes of tumor progress and metastasis, but also required to provide a normal human mammary microenvironment for the breast cancer cells to proliferate and metastasize. Numerous mouse models have been introduced in the literature but failed to achieve the two requirements simultaneously. In this study, we developed a novel human breast tissue-derived orthotopic and metastatic (BOM) mouse model of breast cancer, in which the normal human breast tissues were implanted subcutaneously to create a normal human mammary microenvironment, after which the human breast cancer cells were inoculated into the implants. The BOM model not only mimicked the whole processes of tumor progress and metastasis, but also allowed the orthotopic human breast cancer cells to proliferate in the normal human mammary microenvironment, and finally metastasize preferentially to the distant human tissues. Consequently, the BOM model contributed to the orthotopic tumor formation of 100% (11/11) and the metastatic tumor formation of 72.7% (8/11) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Green Fluorescent Proteins |2 NLM | |
| 650 | 7 | |a 147336-22-9 |2 NLM | |
| 700 | 1 | |a Xia, Tian-Song |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Xiao-An |e verfasserin |4 aut | |
| 700 | 1 | |a Ding, Qiang |e verfasserin |4 aut | |
| 700 | 1 | |a Du, Qing |e verfasserin |4 aut | |
| 700 | 1 | |a Yin, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Shui |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Breast cancer research and treatment |d 1992 |g 120(2010), 2 vom: 21. Apr., Seite 337-44 |w (DE-627)NLM01302132X |x 1573-7217 |7 nnns |
| 773 | 1 | 8 | |g volume:120 |g year:2010 |g number:2 |g day:21 |g month:04 |g pages:337-44 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10549-009-0391-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 120 |j 2010 |e 2 |b 21 |c 04 |h 337-44 | ||